Explore the words cloud of the AutoCapSyn project. It provides you a very rough idea of what is the project "AutoCapSyn" about.
The following table provides information about the project.
Coordinator |
SYNPLE CHEM AG
Organization address contact info |
Coordinator Country | Switzerland [CH] |
Total cost | 71˙429 € |
EC max contribution | 50˙000 € (70%) |
Programme |
1. H2020-EU.3. (PRIORITY 'Societal challenges) 2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs) 3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies) |
Code Call | H2020-SMEInst-2018-2020-1 |
Funding Scheme | SME-1 |
Starting year | 2019 |
Duration (year-month-day) | from 2019-10-01 to 2020-03-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | SYNPLE CHEM AG | CH (ZURICH) | coordinator | 50˙000.00 |
Drug discovery continues to rely on the synthesis of tiny amounts of candidate molecules using unpredictable protocols that require highly trained specialists. As such, it remains expensive, time-consuming, unsafe, and environmentally unfriendly. Declining productivity, high costs, and safety issues, have driven a large amount of chemical synthesis to lower cost countries, which introduces delays and uncertainty in the drug discovery process, where the flexibility to rapidly prepare new molecules in response to biological data is critical to success.
In order to address these problems, Synple has developed an innovative, benchtop, capsule-based machine that synthesises new molecules at the touch of a button. This fully automated technology offers significant timesaving and productivity benefits. With all necessary components for the safe execution of the reaction and purification of the resulting products enclosed within the capsule, the user’s exposure to toxic agents will be minimised. Use of the automated machines with the innovative capsules will aid chemical research organisations as they can greatly simplify the way in which key chemical scaffolds are produced while providing a safer and more efficient work environment.
The first goal of this feasibility study is to determine if the technology is technically feasible in its current form (robustness and compatibility with customer’s current work flow). The second goal – exploration of the commercially feasibility − will be achieved by gaining a deeper insight in the market size and dynamics, as well as determining frequency of use. Upon successful completion of these goals, we aim to then establish the steps required for commercial launch. Key parameters include: defining the supply chain and pricing structure and identifying the most appropriate sales, marketing and distribution channels. Ultimately, Synple aims to use this feasibility study to identify the optimal route to becoming the market leader.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "AUTOCAPSYN" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "AUTOCAPSYN" are provided by the European Opendata Portal: CORDIS opendata.